Vanderbilt-Ingrim Cancer Center — Nashville, Tennessee

Vanderbilt-Ingrim Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 49/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingrim Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma.

Sponsors: Kite, A Gilead Company.

Sponsor Feasibility Report

Trust Score: 49/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingrim Cancer Center?

Vanderbilt-Ingrim Cancer Center has a Crixeo Trust Score of 49/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingrim Cancer Center conducted?

Vanderbilt-Ingrim Cancer Center has 2 clinical trials on record. Their work covers Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma.

Is Vanderbilt-Ingrim Cancer Center accredited by Crixeo Health?

Vanderbilt-Ingrim Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingrim Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.